{
  "DOI": "10.1186/s40246-023-00510-7",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-023-00510-7",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\u003cjats:title\u003eBackground\u003c/jats:title\u003e\u003cjats:p\u003eCancer predisposition is most often studied in the context of single cancers. However, inherited cancer predispositions can also give rise to multiple primary cancers. Yet, there is a paucity of studies on genetic predisposition in multiple primary cancers, especially those outside of well-defined cancer predisposition syndromes. This study aimed to identify germline variants associated with dual primary cancers of the breast and lung.\u003c/jats:p\u003e\u003c/jats:sec\u003e\u003cjats:sec\u003e\u003cjats:title\u003eMethods\u003c/jats:title\u003e\u003cjats:p\u003eExome sequencing was performed on germline DNA from 55 Singapore patients (52 [95%] never-smokers) with dual primaries in the breast and lung, confirmed by histopathology. Using two large control cohorts: the local SG10K_Health (n = 9770) and gnomAD non-cancer East Asians (n = 9626); and two additional local case cohorts of early-onset or familial breast cancer (n = 290), and lung cancer (n = 209), variants were assessed for pathogenicity in accordance with ACMG/AMP guidelines. In particular, comparisons were made with known pathogenic or likely pathogenic variants in the ClinVar database, pathogenicity predictions were obtained from in silico prediction software, and case–control association analyses were performed.\u003c/jats:p\u003e\u003c/jats:sec\u003e\u003cjats:sec\u003e\u003cjats:title\u003eResults\u003c/jats:title\u003e\u003cjats:p\u003eAltogether, we identified 19 pathogenic or likely pathogenic variants from 16 genes, detected in 17 of 55 (31%) patients. Six of the 19 variants were identified using ClinVar, while 13 variants were classified pathogenic or likely pathogenic using ACMG/AMP guidelines. The 16 genes include well-known cancer predisposition genes such as\u003cjats:italic\u003eBRCA2, TP53,\u003c/jats:italic\u003eand\u003cjats:italic\u003eRAD51D;\u003c/jats:italic\u003ebut also lesser known cancer genes\u003cjats:italic\u003eEXT2\u003c/jats:italic\u003e,\u003cjats:italic\u003eWWOX\u003c/jats:italic\u003e,\u003cjats:italic\u003eGATA2\u003c/jats:italic\u003e, and\u003cjats:italic\u003eGPC3.\u003c/jats:italic\u003eMost of these genes are involved in DNA damage repair, reaffirming the role of impaired DNA repair mechanisms in the development of multiple malignancies. These variants warrant further investigations in additional populations.\u003c/jats:p\u003e\u003c/jats:sec\u003e\u003cjats:sec\u003e\u003cjats:title\u003eConclusions\u003c/jats:title\u003e\u003cjats:p\u003eWe have identified both known and novel variants significantly enriched in patients with primary breast and lung malignancies, expanding the body of known cancer predisposition variants for both breast and lung cancer. These variants are mostly from genes involved in DNA repair, affirming the role of impaired DNA repair in the predisposition and development of multiple cancers.\u003c/jats:p\u003e\u003c/jats:sec\u003e",
  "alternative-id": [
    "510"
  ],
  "article-number": "66",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "10 May 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "10 July 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "17 July 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Date",
      "name": "change_date",
      "order": 4,
      "value": "14 August 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Type",
      "name": "change_type",
      "order": 5,
      "value": "Correction"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Details",
      "name": "change_details",
      "order": 6,
      "value": "A Correction to this paper has been published:"
    },
    {
      "URL": "https://doi.org/10.1186/s40246-023-00518-z",
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Details",
      "name": "change_details",
      "order": 7,
      "value": "https://doi.org/10.1186/s40246-023-00518-z"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Written informed consent was obtained from all patients and the study was approved by the SingHealth Centralised Institutional Review Board (CIRB Ref: 2018/2147 and 2018/2963)."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "P.A. reports receiving travel support and/or honoraria from AstraZeneca, DKSH, Eisai, Bristol Myers Squibb, Lilly, Novartis, Pfizer, Roche, and MSD, all of which are outside the submitted work. M.-H.T. reports being a director, shareholder, and Chief Executive Officer of Lucence, outside of the submitted work. S.-C.L. reports grant support/research collaborations with Pfizer, Eisai, Taiho, ACT Genomics, Bayer, and MSD; advisory board/speaker invitations from Pfizer, Novartis, Astra Zeneca, ACT Genomics, Eli Lilly, MSD, Roche, Eisai and Daiichi-Sankyo; conference support from Amgen, Pfizer and Roche, all of which are outside the submitted work. No other disclosures were reported."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Lee",
      "given": "Ning-Yuan",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Hum",
      "given": "Melissa",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zihara",
      "given": "Sabna",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Lanying",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Myint",
      "given": "Matthew K.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lim",
      "given": "Darren Wan-Teck",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Toh",
      "given": "Chee-Keong",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Skanderup",
      "given": "Anders",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Samol",
      "given": "Jens",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tan",
      "given": "Min-Han",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ang",
      "given": "Peter",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lee",
      "given": "Soo-Chin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tan",
      "given": "Eng-Huat",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lai",
      "given": "Gillianne G. Y.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tan",
      "given": "Daniel S. W.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yap",
      "given": "Yoon-Sim",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lee",
      "given": "Ann S. G.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        7,
        17
      ]
    ],
    "date-time": "2023-07-17T14:02:06Z",
    "timestamp": 1689602526000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        12,
        17
      ]
    ],
    "date-time": "2023-12-17T06:20:05Z",
    "timestamp": 1702794005000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        18
      ]
    ],
    "date-time": "2024-03-18T12:50:42Z",
    "timestamp": 1710766242677
  },
  "is-referenced-by-count": 2,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2023,
        7,
        17
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2023,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            7,
            17
          ]
        ],
        "date-time": "2023-07-17T00:00:00Z",
        "timestamp": 1689552000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            7,
            17
          ]
        ],
        "date-time": "2023-07-17T00:00:00Z",
        "timestamp": 1689552000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00510-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-023-00510-7/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00510-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2023,
        7,
        17
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        7,
        17
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1136/esmoopen-2017-000172",
      "author": "A Vogt",
      "doi-asserted-by": "crossref",
      "issue": "2",
      "journal-title": "ESMO Open",
      "key": "510_CR1",
      "unstructured": "Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T, et al. Multiple primary tumours: challenges and approaches, a review. ESMO Open. 2017;2(2): e000172.",
      "volume": "2",
      "year": "2017"
    },
    {
      "DOI": "10.3389/fonc.2018.00427",
      "author": "R Wang",
      "doi-asserted-by": "crossref",
      "first-page": "427",
      "journal-title": "Front Oncol",
      "key": "510_CR2",
      "unstructured": "Wang R, Yin Z, Liu L, Gao W, Li W, Shu Y, et al. Second primary lung cancer after breast cancer: a population-based study of 6269 women. Front Oncol. 2018;8:427.",
      "volume": "8",
      "year": "2018"
    },
    {
      "DOI": "10.1016/S0959-8049(02)00089-8",
      "author": "M Prochazka",
      "doi-asserted-by": "crossref",
      "first-page": "1520",
      "issue": "11",
      "journal-title": "Eur J Cancer",
      "key": "510_CR3",
      "unstructured": "Prochazka M, Granath F, Ekbom A, Shields PG, Hall P. Lung cancer risks in women with previous breast cancer. Eur J Cancer. 2002;38(11):1520–5.",
      "volume": "38",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.ijrobp.2006.12.011",
      "author": "YM Kirova",
      "doi-asserted-by": "crossref",
      "first-page": "359",
      "issue": "2",
      "journal-title": "Int J Radiat Oncol Biol Phys",
      "key": "510_CR4",
      "unstructured": "Kirova YM, Gambotti L, De Rycke Y, Vilcoq JR, Asselain B, Fourquet A. Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review. Int J Radiat Oncol Biol Phys. 2007;68(2):359–63.",
      "volume": "68",
      "year": "2007"
    },
    {
      "author": "RC Go",
      "first-page": "455",
      "issue": "3",
      "journal-title": "J Natl Cancer Inst",
      "key": "510_CR5",
      "unstructured": "Go RC, King MC, Bailey-Wilson J, Elston RC, Lynch HT. Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis. J Natl Cancer Inst. 1983;71(3):455–61.",
      "volume": "71",
      "year": "1983"
    },
    {
      "DOI": "10.1016/0002-9343(94)90091-4",
      "author": "P Watson",
      "doi-asserted-by": "crossref",
      "first-page": "516",
      "issue": "6",
      "journal-title": "Am J Med",
      "key": "510_CR6",
      "unstructured": "Watson P, Vasen HF, Mecklin JP, Järvinen H, Lynch HT. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med. 1994;96(6):516–20.",
      "volume": "96",
      "year": "1994"
    },
    {
      "DOI": "10.3390/cancers11040441",
      "author": "S Coco",
      "doi-asserted-by": "crossref",
      "first-page": "441",
      "issue": "4",
      "journal-title": "Cancers (Basel).",
      "key": "510_CR7",
      "unstructured": "Coco S, Bonfiglio S, Cittaro D, Vanni I, Mora M, Genova C, et al. Integrated somatic and germline whole-exome sequencing analysis in women with lung cancer after a previous breast cancer. Cancers (Basel). 2019;11(4):441.",
      "volume": "11",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.ajhg.2018.04.013",
      "author": "J Whitworth",
      "doi-asserted-by": "crossref",
      "first-page": "3",
      "issue": "1",
      "journal-title": "Am J Hum Genet",
      "key": "510_CR8",
      "unstructured": "Whitworth J, Smith PS, Martin J-E, West H, Luchetti A, Rodger F, et al. Comprehensive cancer-predisposition gene testing in an adult multiple primary tumor series shows a broad range of deleterious variants and atypical tumor phenotypes. Am J Hum Genet. 2018;103(1):3–18.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s12916-022-02535-6",
      "author": "TB Cavazos",
      "doi-asserted-by": "crossref",
      "first-page": "332",
      "issue": "1",
      "journal-title": "BMC Med",
      "key": "510_CR9",
      "unstructured": "Cavazos TB, Kachuri L, Graff RE, Nierenberg JL, Thai KK, Alexeeff S, et al. Assessment of genetic susceptibility to multiple primary cancers through whole-exome sequencing in two large multi-ancestry studies. BMC Med. 2022;20(1):332.",
      "volume": "20",
      "year": "2022"
    },
    {
      "DOI": "10.1634/theoncologist.12-1-20",
      "author": "MJ Hayat",
      "doi-asserted-by": "crossref",
      "first-page": "20",
      "issue": "1",
      "journal-title": "Oncologist",
      "key": "510_CR10",
      "unstructured": "Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist. 2007;12(1):20–37.",
      "volume": "12",
      "year": "2007"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "crossref",
      "first-page": "405",
      "issue": "5",
      "journal-title": "Genet Med",
      "key": "510_CR11",
      "unstructured": "Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–23.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1002/cncr.11214",
      "author": "LB Zablotska",
      "doi-asserted-by": "crossref",
      "first-page": "1404",
      "issue": "6",
      "journal-title": "Cancer",
      "key": "510_CR12",
      "unstructured": "Zablotska LB, Neugut AI. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer. 2003;97(6):1404–11.",
      "volume": "97",
      "year": "2003"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-21-1287",
      "author": "S Mukherjee",
      "doi-asserted-by": "crossref",
      "first-page": "1450",
      "issue": "7",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "510_CR13",
      "unstructured": "Mukherjee S, Bandlamudi C, Hellmann MD, Kemel Y, Drill E, Rizvi H, et al. Germline pathogenic variants impact clinicopathology of advanced lung cancer. Cancer Epidemiol Biomark Prev. 2022;31(7):1450–9.",
      "volume": "31",
      "year": "2022"
    },
    {
      "DOI": "10.1038/nrclinonc.2016.90",
      "author": "N Tung",
      "doi-asserted-by": "crossref",
      "first-page": "581",
      "issue": "9",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "510_CR14",
      "unstructured": "Tung N, Domchek SM, Stadler Z, Nathanson KL, Couch F, Garber JE, et al. Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nat Rev Clin Oncol. 2016;13(9):581–8.",
      "volume": "13",
      "year": "2016"
    },
    {
      "DOI": "10.1001/jamaoncol.2017.0424",
      "author": "FJ Couch",
      "doi-asserted-by": "crossref",
      "first-page": "1190",
      "issue": "9",
      "journal-title": "JAMA Oncol",
      "key": "510_CR15",
      "unstructured": "Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 2017;3(9):1190–6.",
      "volume": "3",
      "year": "2017"
    },
    {
      "DOI": "10.1200/PO.16.00066",
      "author": "AW Kurian",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "JCO Precis Oncol",
      "key": "510_CR16",
      "unstructured": "Kurian AW, Hughes E, Handorf EA, Gutin A, Allen B, Hartman AR, et al. Breast and ovarian cancer penetrance estimates derived from germline multiple-gene sequencing results in women. JCO Precis Oncol. 2017;1:1–12.",
      "volume": "1",
      "year": "2017"
    },
    {
      "DOI": "10.6004/jnccn.2020.0017",
      "author": "MB Daly",
      "doi-asserted-by": "crossref",
      "first-page": "380",
      "issue": "4",
      "journal-title": "J Natl Comp Cancer Netw",
      "key": "510_CR17",
      "unstructured": "Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, et al. NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020: featured updates to the NCCN guidelines. J Natl Comp Cancer Netw. 2020;18(4):380–91.",
      "volume": "18",
      "year": "2020"
    },
    {
      "DOI": "10.1001/jama.2011.743",
      "author": "V Bonadona",
      "doi-asserted-by": "crossref",
      "first-page": "2304",
      "issue": "22",
      "journal-title": "JAMA",
      "key": "510_CR18",
      "unstructured": "Bonadona V, Bonaïti B, Olschwang S, Grandjouan S, Huiart L, Longy M, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011;305(22):2304–10.",
      "volume": "305",
      "year": "2011"
    },
    {
      "DOI": "10.1001/jama.296.12.1469",
      "author": "J Balmaña",
      "doi-asserted-by": "crossref",
      "first-page": "1469",
      "issue": "12",
      "journal-title": "JAMA",
      "key": "510_CR19",
      "unstructured": "Balmaña J, Stockwell DH, Steyerberg EW, Stoffel EM, Deffenbaugh AM, Reid JE, et al. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA. 2006;296(12):1469–78.",
      "volume": "296",
      "year": "2006"
    },
    {
      "DOI": "10.1101/gad.349431.122",
      "author": "JL Hopkins",
      "doi-asserted-by": "crossref",
      "first-page": "278",
      "issue": "5–6",
      "journal-title": "Genes Dev",
      "key": "510_CR20",
      "unstructured": "Hopkins JL, Lan L, Zou L. DNA repair defects in cancer and therapeutic opportunities. Genes Dev. 2022;36(5–6):278–93.",
      "volume": "36",
      "year": "2022"
    },
    {
      "DOI": "10.1002/ijc.31921",
      "author": "E Girard",
      "doi-asserted-by": "crossref",
      "first-page": "1962",
      "issue": "8",
      "journal-title": "Int J Cancer",
      "key": "510_CR21",
      "unstructured": "Girard E, Eon-Marchais S, Olaso R, Renault AL, Damiola F, Dondon MG, et al. Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing. Int J Cancer. 2019;144(8):1962–74.",
      "volume": "144",
      "year": "2019"
    },
    {
      "DOI": "10.3390/cancers12040829",
      "author": "J Del Valle",
      "doi-asserted-by": "crossref",
      "first-page": "829",
      "issue": "4",
      "journal-title": "Cancers (Basel).",
      "key": "510_CR22",
      "unstructured": "Del Valle J, Rofes P, Moreno-Cabrera JM, López-Dóriga A, Belhadj S, Vargas-Parra G, et al. Exploring the role of mutations in Fanconi anemia genes in hereditary cancer patients. Cancers (Basel). 2020;12(4):829.",
      "volume": "12",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s10549-015-3545-6",
      "author": "MS Ellingson",
      "doi-asserted-by": "crossref",
      "first-page": "435",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "510_CR23",
      "unstructured": "Ellingson MS, Hart SN, Kalari KR, Suman V, Schahl KA, Dockter TJ, et al. Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy. Breast Cancer Res Treat. 2015;153(2):435–43.",
      "volume": "153",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s00432-018-2763-9",
      "author": "S Bonache",
      "doi-asserted-by": "crossref",
      "first-page": "2495",
      "issue": "12",
      "journal-title": "J Cancer Res Clin Oncol",
      "key": "510_CR24",
      "unstructured": "Bonache S, Esteban I, Moles-Fernández A, Tenés A, Duran-Lozano L, Montalban G, et al. Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings. J Cancer Res Clin Oncol. 2018;144(12):2495–513.",
      "volume": "144",
      "year": "2018"
    },
    {
      "DOI": "10.3390/ijms161226192",
      "author": "K Zins",
      "doi-asserted-by": "crossref",
      "first-page": "29643",
      "issue": "12",
      "journal-title": "Int J Mol Sci",
      "key": "510_CR25",
      "unstructured": "Zins K, Frech B, Taubenschuss E, Schneeberger C, Abraham D, Schreiber M. Association of the rs1346044 polymorphism of the werner syndrome gene RECQL2 with increased risk and premature onset of breast cancer. Int J Mol Sci. 2015;16(12):29643–53.",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.3389/fonc.2019.01429",
      "author": "J Oliver",
      "doi-asserted-by": "crossref",
      "first-page": "1429",
      "journal-title": "Front Oncol",
      "key": "510_CR26",
      "unstructured": "Oliver J, Quezada Urban R, Franco Cortés CA, Díaz Velásquez CE, Montealegre Paez AL, Pacheco-Orozco RA, et al. Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: a genomic epidemiology approach. Front Oncol. 2019;9:1429.",
      "volume": "9",
      "year": "2019"
    },
    {
      "DOI": "10.3390/cancers14071647",
      "author": "L Gómez-Flores-Ramos",
      "doi-asserted-by": "crossref",
      "first-page": "1647",
      "issue": "7",
      "journal-title": "Cancers (Basel).",
      "key": "510_CR27",
      "unstructured": "Gómez-Flores-Ramos L, Barraza-Arellano AL, Mohar A, Trujillo-Martínez M, Grimaldo L, Ortiz-Lopez R, et al. Germline variants in cancer genes from young breast cancer Mexican patients. Cancers (Basel). 2022;14(7):1647.",
      "volume": "14",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.canlet.2008.08.002",
      "author": "H Ma",
      "doi-asserted-by": "crossref",
      "first-page": "172",
      "issue": "1",
      "journal-title": "Cancer Lett",
      "key": "510_CR28",
      "unstructured": "Ma H, Hu Z, Wang H, Jin G, Wang Y, Sun W, et al. ERCC6/CSB gene polymorphisms and lung cancer risk. Cancer Lett. 2009;273(1):172–6.",
      "volume": "273",
      "year": "2009"
    },
    {
      "DOI": "10.1200/JCO.19.02760",
      "author": "N Qin",
      "doi-asserted-by": "crossref",
      "first-page": "2728",
      "issue": "24",
      "journal-title": "J Clin Oncol",
      "key": "510_CR29",
      "unstructured": "Qin N, Wang Z, Liu Q, Song N, Wilson CL, Ehrhardt MJ, et al. Pathogenic germline mutations in DNA repair genes in combination with cancer treatment exposures and risk of subsequent neoplasms among long-term survivors of childhood cancer. J Clin Oncol. 2020;38(24):2728–40.",
      "volume": "38",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41586-023-05874-3",
      "author": "W Hill",
      "doi-asserted-by": "crossref",
      "first-page": "159",
      "issue": "7955",
      "journal-title": "Nature",
      "key": "510_CR30",
      "unstructured": "Hill W, Lim EL, Weeden CE, Lee C, Augustine M, Chen K, et al. Lung adenocarcinoma promotion by air pollutants. Nature. 2023;616(7955):159–67.",
      "volume": "616",
      "year": "2023"
    },
    {
      "DOI": "10.1002/gcc.22419",
      "author": "A Heddar",
      "doi-asserted-by": "crossref",
      "first-page": "128",
      "issue": "2",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "510_CR31",
      "unstructured": "Heddar A, Fermey P, Coutant S, Angot E, Sabourin JC, Michelin P, et al. Familial solitary chondrosarcoma resulting from germline EXT2 mutation. Genes Chromosomes Cancer. 2017;56(2):128–34.",
      "volume": "56",
      "year": "2017"
    },
    {
      "DOI": "10.21037/tlcr-19-403",
      "author": "M Liu",
      "doi-asserted-by": "crossref",
      "first-page": "646",
      "issue": "3",
      "journal-title": "Transl Lung Cancer Res",
      "key": "510_CR32",
      "unstructured": "Liu M, Liu X, Suo P, Gong Y, Qu B, Peng X, et al. The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility. Transl Lung Cancer Res. 2020;9(3):646–58.",
      "volume": "9",
      "year": "2020"
    },
    {
      "DOI": "10.1002/path.5288",
      "author": "A Xu",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "issue": "1",
      "journal-title": "J Pathol",
      "key": "510_CR33",
      "unstructured": "Xu A, Wang W, Nie J, Lui VW, Hong B, Lin W. Germline mutation and aberrant transcripts of WWOX in a syndrome with multiple primary tumors. J Pathol. 2019;249(1):19–25.",
      "volume": "249",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.canlet.2015.09.014",
      "author": "AP Sokolenko",
      "doi-asserted-by": "crossref",
      "first-page": "274",
      "issue": "2",
      "journal-title": "Cancer Lett",
      "key": "510_CR34",
      "unstructured": "Sokolenko AP, Suspitsin EN, Kuligina E, Bizin IV, Frishman D, Imyanitov EN. Identification of novel hereditary cancer genes by whole exome sequencing. Cancer Lett. 2015;369(2):274–88.",
      "volume": "369",
      "year": "2015"
    },
    {
      "DOI": "10.1053/j.seminoncol.2016.10.003",
      "author": "S Feurstein",
      "doi-asserted-by": "crossref",
      "first-page": "598",
      "issue": "5",
      "journal-title": "Semin Oncol",
      "key": "510_CR35",
      "unstructured": "Feurstein S, Drazer MW, Godley LA. Genetic predisposition to leukemia and other hematologic malignancies. Semin Oncol. 2016;43(5):598–608.",
      "volume": "43",
      "year": "2016"
    },
    {
      "DOI": "10.1002/ajmg.a.36364",
      "author": "R Kosaki",
      "doi-asserted-by": "crossref",
      "first-page": "993",
      "issue": "4",
      "journal-title": "Am J Med Genet A",
      "key": "510_CR36",
      "unstructured": "Kosaki R, Takenouchi T, Takeda N, Kagami M, Nakabayashi K, Hata K, et al. Somatic CTNNB1 mutation in hepatoblastoma from a patient with Simpson–Golabi–Behmel syndrome and germline GPC3 mutation. Am J Med Genet A. 2014;164(4):993–7.",
      "volume": "164",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.jpedsurg.2021.08.008",
      "author": "CN Grant",
      "doi-asserted-by": "crossref",
      "first-page": "430",
      "issue": "3",
      "journal-title": "J Pediatr Surg",
      "key": "510_CR37",
      "unstructured": "Grant CN, Rhee D, Tracy ET, Aldrink JH, Baertschiger RM, Lautz TB, et al. Pediatric solid tumors and associated cancer predisposition syndromes: workup, management, and surveillance. A summary from the APSA Cancer Committee. J Pediatr Surg. 2022;57(3):430–42.",
      "volume": "57",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41467-020-15461-z",
      "author": "DN Subramanian",
      "doi-asserted-by": "crossref",
      "first-page": "1640",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "510_CR38",
      "unstructured": "Subramanian DN, Zethoven M, McInerny S, Morgan JA, Rowley SM, Lee JEA, et al. Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes. Nat Commun. 2020;11(1):1640.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1200/PO.20.00399",
      "author": "J Chiang",
      "doi-asserted-by": "crossref",
      "first-page": "577",
      "journal-title": "JCO Precis Oncol",
      "key": "510_CR39",
      "unstructured": "Chiang J, Chia TH, Yuen J, Shaw T, Li ST, Binte Ishak ND, et al. Impact of variant reclassification in cancer predisposition genes on clinical care. JCO Precis Oncol. 2021;5:577–84.",
      "volume": "5",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s40246-022-00435-7",
      "author": "NY Lee",
      "doi-asserted-by": "crossref",
      "first-page": "61",
      "issue": "1",
      "journal-title": "Hum Genom",
      "key": "510_CR40",
      "unstructured": "Lee NY, Hum M, Amali AA, Lim WK, Wong M, Myint MK, et al. Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility. Hum Genom. 2022;16(1):61.",
      "volume": "16",
      "year": "2022"
    },
    {
      "DOI": "10.1038/npjgenmed.2015.3",
      "author": "ESY Wong",
      "doi-asserted-by": "crossref",
      "first-page": "15003",
      "journal-title": "NPJ Genom Med",
      "key": "510_CR41",
      "unstructured": "Wong ESY, Shekar S, Met-Domestici M, Chan C, Sze M, Yap YS, et al. Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore. NPJ Genom Med. 2016;1:15003.",
      "volume": "1",
      "year": "2016"
    },
    {
      "DOI": "10.1200/JCO.20.02785",
      "author": "AW Kurian",
      "doi-asserted-by": "crossref",
      "first-page": "1631",
      "issue": "15",
      "journal-title": "J Clin Oncol",
      "key": "510_CR42",
      "unstructured": "Kurian AW, Ward KC, Abrahamse P, Bondarenko I, Hamilton AS, Deapen D, et al. Time trends in receipt of germline genetic testing and results for women diagnosed with breast cancer or ovarian cancer, 2012–2019. J Clin Oncol. 2021;39(15):1631–40.",
      "volume": "39",
      "year": "2021"
    },
    {
      "DOI": "10.1001/jama.2018.13152",
      "author": "J Mersch",
      "doi-asserted-by": "crossref",
      "first-page": "1266",
      "issue": "12",
      "journal-title": "JAMA",
      "key": "510_CR43",
      "unstructured": "Mersch J, Brown N, Pirzadeh-Miller S, Mundt E, Cox HC, Brown K, et al. Prevalence of variant reclassification following hereditary cancer genetic testing. JAMA. 2018;320(12):1266–74.",
      "volume": "320",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41436-018-0063-z",
      "author": "SA Turner",
      "doi-asserted-by": "crossref",
      "first-page": "426",
      "issue": "2",
      "journal-title": "Genet Med",
      "key": "510_CR44",
      "unstructured": "Turner SA, Rao SK, Morgan RH, Vnencak-Jones CL, Wiesner GL. The impact of variant classification on the clinical management of hereditary cancer syndromes. Genet Med. 2019;21(2):426–30.",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1101/201178",
      "doi-asserted-by": "crossref",
      "key": "510_CR45",
      "unstructured": "Poplin R, Ruano-Rubio V, DePristo MA, Fennell TJ, Carneiro MO, Van der Auwera GA, et al. Scaling accurate genetic variant discovery to tens of thousands of samples. bioRxiv. 2018:201178."
    },
    {
      "DOI": "10.1093/nar/gkq285",
      "author": "K Wang",
      "doi-asserted-by": "crossref",
      "issue": "16",
      "journal-title": "Nucleic Acids Res",
      "key": "510_CR46",
      "unstructured": "Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16): e164.",
      "volume": "38",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.ajhg.2016.08.016",
      "author": "NM Ioannidis",
      "doi-asserted-by": "crossref",
      "first-page": "877",
      "issue": "4",
      "journal-title": "Am J Hum Genet",
      "key": "510_CR47",
      "unstructured": "Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99(4):877–85.",
      "volume": "99",
      "year": "2016"
    },
    {
      "DOI": "10.1038/ng.2892",
      "author": "M Kircher",
      "doi-asserted-by": "crossref",
      "first-page": "310",
      "issue": "3",
      "journal-title": "Nat Genet",
      "key": "510_CR48",
      "unstructured": "Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310–5.",
      "volume": "46",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nprot.2009.86",
      "author": "P Kumar",
      "doi-asserted-by": "crossref",
      "first-page": "1073",
      "issue": "7",
      "journal-title": "Nat Protoc",
      "key": "510_CR49",
      "unstructured": "Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073–81.",
      "volume": "4",
      "year": "2009"
    },
    {
      "author": "I Adzhubei",
      "first-page": "7201",
      "issue": "1",
      "journal-title": "Curr Protoc Hum Genet",
      "key": "510_CR50",
      "unstructured": "Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013;76(1):7201–741.",
      "volume": "76",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nmeth0810-575",
      "author": "JM Schwarz",
      "doi-asserted-by": "crossref",
      "first-page": "575",
      "issue": "8",
      "journal-title": "Nat Methods",
      "key": "510_CR51",
      "unstructured": "Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575–6.",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nature19057",
      "author": "M Lek",
      "doi-asserted-by": "crossref",
      "first-page": "285",
      "issue": "7616",
      "journal-title": "Nature",
      "key": "510_CR52",
      "unstructured": "Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–91.",
      "volume": "536",
      "year": "2016"
    },
    {
      "key": "510_CR53",
      "unstructured": "PRECISE. SG10K, about SG10K_Health. Available from: https://web.archive.org/web/20210624043126/https://www.npm.sg/collaborate/partners/sg10k/."
    },
    {
      "DOI": "10.1038/s41588-019-0569-6",
      "author": "J Chen",
      "doi-asserted-by": "crossref",
      "first-page": "177",
      "issue": "2",
      "journal-title": "Nat Genet",
      "key": "510_CR54",
      "unstructured": "Chen J, Yang H, Teo ASM, Amer LB, Sherbaf FG, Tan CQ, et al. Genomic landscape of lung adenocarcinoma in East Asians. Nat Genet. 2020;52(2):177–86.",
      "volume": "52",
      "year": "2020"
    },
    {
      "key": "510_CR55",
      "unstructured": "R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available from: https://r-project.org/."
    },
    {
      "DOI": "10.1093/nar/gkac1096",
      "author": "J Wang",
      "doi-asserted-by": "crossref",
      "first-page": "D384",
      "issue": "D1",
      "journal-title": "Nucleic Acids Res",
      "key": "510_CR56",
      "unstructured": "Wang J, Chitsaz F, Derbyshire MK, Gonzales NR, Gwadz M, Lu S, et al. The conserved domain database in 2023. Nucleic Acids Res. 2023;51(D1):D384–8.",
      "volume": "51",
      "year": "2023"
    },
    {
      "DOI": "10.1073/pnas.0506580102",
      "author": "A Subramanian",
      "doi-asserted-by": "crossref",
      "first-page": "15545",
      "issue": "43",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "510_CR57",
      "unstructured": "Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–50.",
      "volume": "102",
      "year": "2005"
    }
  ],
  "reference-count": 57,
  "references-count": 57,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-023-00510-7"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}